FOXA1 protein expression and survival of breast cancer patients. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 3, p. 422–426, 2022. DOI: 10.47750/pnr.2022.13.03.064. Disponível em: https://mail.pnrjournal.com/index.php/home/article/view/2353.. Acesso em: 13 jun. 2026.